1
|
Wang CZ, Luo X, Zhang B, et al:
Notoginseng enhances anti-cancer effect of 5-fluorouracil on human
colorectal cancer cells. Cancer Chemother Pharmacol. 60:69–79.
2007. View Article : Google Scholar : PubMed/NCBI
|
2
|
Chen J, Huang XF and Katsifis A:
Activation of signal pathways and the resistance to anti-EGFR
treatment in colorectal cancer. J Cell Biochem. 111:1082–1086.
2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Kinzler KW and Vogelstein B: Lessons from
hereditary colorectal cancer. Cell. 87:159–170. 1996. View Article : Google Scholar : PubMed/NCBI
|
4
|
Jang JY, Lee JH, Shin HK, Choi YH, Lee JD
and Choi BT: Partially purified Asiasari radix inhibits
melanogenesis through extracellular signal-regulated kinase
signaling in B16F10 cells. Int J Mol Med. 25:287–292. 2010.
|
5
|
Suzuki Y, Yuzurihara M, Hibino T, Yano S
and Kase Y: Aqueous extract of Asiasari radix inhibits
formalin-induced hyperalgesia via NMDA receptors. J Ethnopharmacol.
123:128–133. 2009.
|
6
|
Kim HM and Moon YS: Asiasari radix
inhibits immunoglobulinE production on experimental models in
vitro and in vivo. Immunopharmacol Immunotoxicol.
21:469–481. 1999. View Article : Google Scholar
|
7
|
Hashimoto K, Yanagisawa T, Okui Y, Ikeya
Y, Maruno M and Fujita T: Studies on anti-allergic components in
the roots of Asiasarum sieboldi. Planta Med. 60:124–127.
1994. View Article : Google Scholar : PubMed/NCBI
|
8
|
Han Y, Kwon EH and Kim SJ: Protection of
brain cells against AMPA-induced damage by Asiasari Radix
extracts. Phytother Res. 17:882–886. 2003. View Article : Google Scholar : PubMed/NCBI
|
9
|
Han Y and Kim SJ: Memory enhancing actions
of Asiasari radix extracts via activation of insulin
receptor and extracellular signal regulated kinase (ERK) I/II in
rat hippocampus. Brain Res. 974:193–201. 2003.PubMed/NCBI
|
10
|
Takasaki M, Konoshima T, Yasuda I, Hamano
T and Tokuda H: Inhibitory effects of shouseiryu-to on two-stage
carcinogenesis. II. Anti-tumor-promoting activities of lignans from
Asiasarum heterotropoides var mandshuricum. Biol Pharm Bull.
20:776–780. 1997. View Article : Google Scholar : PubMed/NCBI
|
11
|
Ramasamy S, Abdul Wahab N, Zainal Abidin
N, Manickam S and Zakaria Z: Growth inhibition of human gynecologic
and colon cancer cells by Phyllanthus watsonii through
apoptosis induction. PLoS One. 7:e347932012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Takara K, Horibe S, Obata Y, Yoshikawa E,
Ohnishi N and Yokoyama T: Effects of 19 herbal extracts on the
sensitivity to paclitaxel or 5-fluorouracil in HeLa cells. Biol
Pharm Bull. 28:138–142. 2005. View Article : Google Scholar : PubMed/NCBI
|
13
|
Korsmeyer SJ, Shutter JR, Veis DJ, Merry
DE and Oltvai ZN: Bcl-2/Bax: a rheostat that regulates an
anti-oxidant pathway and cell death. Semin Cancer Biol. 4:327–332.
1993.PubMed/NCBI
|
14
|
Pei D, Zhang Y and Zheng J: Regulation of
p53: a collaboration between Mdm2 and Mdmx. Oncotarget. 3:228–235.
2012.PubMed/NCBI
|
15
|
Futamura M, Kamino H, Miyamoto Y, et al:
Possible role of semaphorin 3F, a candidate tumor suppressor gene
at 3p21.3, in p53-regulated tumor angiogenesis suppression. Cancer
Res. 67:1451–1460. 2007. View Article : Google Scholar : PubMed/NCBI
|
16
|
Tanikawa C, Nakagawa H, Furukawa Y,
Nakamura Y and Matsuda K: CLCA2 as a p53-inducible senescence
mediator. Neoplasia. 14:141–149. 2012.PubMed/NCBI
|
17
|
Rahman-Roblick R, Roblick UJ, Hellman U,
et al: p53 targets identified by protein expression profiling. Proc
Natl Acad Sci U S A. 104:5401–5406. 2007. View Article : Google Scholar : PubMed/NCBI
|
18
|
Hollstein M, Sidransky D, Vogelstein B and
Harris CC: p53 mutations in human cancers. Science. 253:49–53.
1991. View Article : Google Scholar : PubMed/NCBI
|
19
|
Braithwaite AW, Royds JA and Jackson P:
The p53 story: layers of complexity. Carcinogenesis. 26:1161–1169.
2005. View Article : Google Scholar : PubMed/NCBI
|
20
|
El-Deiry WS: The role of p53 in
chemosensitivity and radiosensitivity. Oncogene. 22:7486–7495.
2003. View Article : Google Scholar : PubMed/NCBI
|
21
|
Reisman D and Loging WT: Transcriptional
regulation of the p53 tumor suppressor gene. Semin Cancer Biol.
8:317–324. 1998. View Article : Google Scholar : PubMed/NCBI
|
22
|
Honda R, Tanaka H and Yasuda H:
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.
FEBS Lett. 420:25–27. 1997. View Article : Google Scholar : PubMed/NCBI
|
23
|
Sun X, Shimizu H and Yamamoto K:
Identification of a novel p53 promoter element involved in
genotoxic stress-inducible p53 gene expression. Mol Cell Biol.
15:4489–4496. 1995.PubMed/NCBI
|
24
|
Haupt S, Berger M, Goldberg Z and Haupt Y:
Apoptosis - the p53 network. J Cell Sci. 116:4077–4085. 2003.
View Article : Google Scholar : PubMed/NCBI
|